ERH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.764400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.685600E-01
Normal-vs-Stage2
9.820000E-01
Normal-vs-Stage3
6.545000E-01
Normal-vs-Stage4
9.962200E-01
Stage1-vs-Stage2
9.343800E-01
Stage1-vs-Stage3
5.550400E-01
Stage1-vs-Stage4
9.705400E-01
Stage2-vs-Stage3
4.534600E-01
Stage2-vs-Stage4
9.857000E-01
Stage3-vs-Stage4
6.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.280400E-01
Normal-vs-AfricanAmerican
3.660800E-01
Normal-vs-Asian
6.800600E-01
Caucasian-vs-AfricanAmerican
2.683000E-01
Caucasian-vs-Asian
3.362600E-01
AfricanAmerican-vs-Asian
7.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.322000E-01
Normal-vs-Female
8.645800E-01
Male-vs-Female
3.142600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.689200E-01
Normal-vs-Age(41-60Yrs)
6.176000E-01
Normal-vs-Age(61-80Yrs)
8.615000E-01
Normal-vs-Age(81-100Yrs)
9.001000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.085000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.067000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.933200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.987900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.636200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.816200E-01
Normal-vs-Daily Drinker
9.546400E-01
Normal-vs-Weekly Drinker
9.175000E-01
Normal-vs-Occasional Drinker
4.919600E-01
Normal-vs-Social Drinker
9.354000E-01
Non Drinker-vs-Daily Drinker
8.369800E-01
Non Drinker-vs-Weekly Drinker
9.850400E-01
Non Drinker-vs-Occasional Drinker
1.686370E-01
Non Drinker-vs-Social Drinker
8.476800E-01
Daily Drinker-vs-Weekly Drinker
8.937600E-01
Daily Drinker-vs-Occasional Drinker
2.819400E-01
Daily Drinker-vs-Social Drinker
9.961800E-01
Weekly Drinker-vs-Occasional Drinker
4.198400E-01
Weekly Drinker-vs-Social Drinker
9.013800E-01
Occasional Drinker-vs-Social Drinker
2.230800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.864800E-01
Normal-vs-Grade 2
9.930600E-01
Normal-vs-Grade 3
9.935800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.924000E-01
Grade 1-vs-Grade 3
6.985800E-01
Grade 1-vs-Grade 4
9.864800E-01
Grade 2-vs-Grade 3
6.924800E-01
Grade 2-vs-Grade 4
9.930600E-01
Grade 3-vs-Grade 4
9.935800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.664600E-01
Normal-vs-NonDiabetic
8.977200E-01
Diabetic-vs-NonDiabetic
9.754100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.157000E-01
Normal-vs-NoPancreatitis
9.580800E-01
Pancreatitis-vs-NoPancreatitis
1.599550E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.693600E-01
Normal-vs-N1
9.925000E-01
N0-vs-N1
6.269800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.797600E-01
Normal-vs-TP53-NonMutant
7.814000E-01
TP53-Mutant-vs-TP53-NonMutant
1.791830E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
